+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Congenital Diaphragmatic Hernia Drugs Market Report 2025 - Product Thumbnail Image

Congenital Diaphragmatic Hernia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 193 Pages
  • Global
From
BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028 - Product Thumbnail Image

BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
Erythropoietin Stimulating Agents Market 2026-2030 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market 2026-2030

  • Report
  • January 2026
  • 303 Pages
  • Global
From
Difficult-to-Express Proteins Market Report 2025 - Product Thumbnail Image

Difficult-to-Express Proteins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Protein Engineering Global Market Report 2025 - Product Thumbnail Image

Protein Engineering Global Market Report 2025

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Loading Indicator